Personal information

No personal information available

Activities

Employment (1)

Center of Healthcare Quality Assessment and Control at the Ministry of Health of the Russian Federation: Moscow, RU

Employment
Source: Self-asserted source
Kirill Matrenin

Education and qualifications (2)

Pirogov Russian National Research Medical University: Moscow, RU

Education
Source: Self-asserted source
Kirill Matrenin

Eötvös Loránd University: Budapest, Pest, HU

Education
Source: Self-asserted source
Kirill Matrenin

Works (6)

Evaluation of clinical efficacy and efficiency of new anticoagulants and sodium-glucose cotransporter 2 inhibitors in patients with coronary artery disease and concomitant cardiovascular diseases

Medical Technologies. Assessment and Choice
2024 | Journal article
Contributors: K.I. Matryonin; E.O. Kurilovich; V.K. Fedyaeva; R.A. Teryan
Source: check_circle
Crossref

Assessment of the impact of procurement centralization on the drug provision for patients within the High-Cost Nosology Program in the Russian Federation

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
2024-11-05 | Journal article
Contributors: V. V. Omelyanovskiy; V. A. Ryagina; A. G. Kharitonova; K. I. Matrenin; A. A. Kingshott; O. V. Ashikhmina; M. V. Zhirov
Source: check_circle
Crossref

Effect of centralized procurement of drugs for chronic lymphocytic leukemia

Medical Technologies. Assessment and Choice
2023 | Journal article
Contributors: V.V. Omelyanovskiy; D.G. Shchurov; V.V. Kalinichenko; A.G. Kharitonova; N.V. Ignatieva; K.I. Matrenin; V.I. Ryagina; S.A. Zaveryachev; I.V. Sorokovikov; V.S. Dombrovskiy
Source: check_circle
Crossref

Pharmacoeconomic analysis of antithrombotic therapy in patients with acute coronary syndrome and patients with atrial fibrillation who underwent percutaneous coronary intervention

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
2023-01-18 | Journal article
Contributors: V. А. Ryagina; К. I. Matrenin; D. G. Shchurov; Т. S. Teptsova
Source: check_circle
Crossref

Economic evaluation of PCSK9 inhibitors inclusion in the list of medicines for outpatient preferential drug provision («23 INNs» list) for secondary prevention of cardiovascular events

Medical Technologies. Assessment and Choice
2022 | Journal article
Contributors: P.A. Mukhortova; T.O. Bessonova; R.A. Teryan; O.S. Shemyakova; K.I. Matrenin; A.D. Bagdasarov; N.Z. Musina
Source: check_circle
Crossref

Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology
2021-04-29 | Journal article
Contributors: V. A. Lemeshko; K. I. Matrenin; V. V. Omelyanovskiy; Yu. V. Vasilyeva; G. R. Khachatryan; L. A. Kolganov
Source: check_circle
Crossref